Correlation of Molecular Biomarkers With Biopsy Findings and Outcomes in Renal Transplant Recipients

Completed

Conditions studied: Delayed Graft Function

In brief

This is a single-center, prospective, non-randomized, observational study to evaluate specific proteogenomic biomarker panels for acute rejection (AR) and chronic allograft nephropathy/interstitial fibrosis and tubular atrophy (CAN/IFTA) in blood, urine and kidney tissue (biopsy) in kidney transplant recipients. Proteogenomic profiles will be routinely monitored over one year after enrollment.

Key facts

Study ID

NCT02463253

Run by

University of California, Davis

People needed

20

Starts

2015-04-01

Expected to finish

2016-05-01

Last updated by the study team

2016-05-25

Who can join

Age: 18 and older, up to 82. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• Need for combined organ transplantation with an extra-renal organ and/or islet cell transplant.
• Recipients of previous non-renal solid organ and/or islet cell transplantation
• Infection with HIV.
• Inability or unwillingness of a participant and/or guardian to provide informed consent

Where it is running

• University of California, Davis Transplant Center — Sacramento, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.